Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease

被引：6
|
作者：
Katagishi, Daiki [1 ]
Yasuda, Daisuke [1 ]
Takahashi, Kyoko [2 ]
Nakamura, Shigeo [2 ]
Mashino, Tadahiko [1 ]
Ohe, Tomoyuki [1 ]
机构：
[1] Keio Univ, Fac Pharm, Dept Pharmaceut Sci, 1-5-30 Shibakoen,Minato Ku, Tokyo, Japan
[2] Nippon Med Sch, Dept Chem, 1-7-1 Kyonan Cho,Musashino, Tokyo, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2023年 / 80卷
关键词：
Fullerene; COVID-19; SARS-CoV-2; Main protease; REVERSE TRANSCRIPTASE INHIBITION; C-60; POLYMERASE;
D O I：
10.1016/j.bmcl.2022.129121
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of COVID-19, and its main protease is one of the enzymes essential for its growth and is considered a drug discovery target. In this study, we evaluated the inhibitory activities of a variety of fullerene derivatives, including newly synthesized derivatives, against the main protease of SARS-CoV-2. As a result, the malonic acid-type fullerene derivatives showed the strongest inhibitory activity.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
    Forrestall, Katrina L.
    Burley, Darcy E.
    Cash, Meghan K.
    Pottie, Ian R.
    Darvesh, Sultan
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 335
  • [32] The SARS-CoV-2 main protease as drug target
    Ullrich, Sven
    Nitsche, Christoph
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (17)
  • [33] Potential protease inhibitors and their combinations to block SARS-CoV-2
    Abhinand, Chandran S.
    Nair, Achuthsankar S.
    Krishnamurthy, Anand
    Oommen, Oommen V.
    Sudhakaran, Perumana R.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (02) : 903 - 917
  • [34] In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease
    Palanisamy, Kandhan
    Maiyelvaganan, K. Rudharachari
    Kamalakannan, Shanmugasundaram
    Thilagavathi, Ramasamy
    Selvam, Chelliah
    Prakash, Muthuramalingam
    MOLECULAR SIMULATION, 2023, 49 (02) : 175 - 185
  • [35] Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Sayed, Ahmed M.
    Alhadrami, Hani A.
    El-Gendy, Ahmed O.
    Shamikh, Yara, I
    Belbahri, Lassaad
    Hassan, Hossam M.
    Abdelmohsen, Usama Ramadan
    Rateb, Mostafa E.
    MICROORGANISMS, 2020, 8 (07) : 1 - 17
  • [36] Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
    Jimenez-Alberto, Alicia
    Maria Ribas-Aparicio, Rosa
    Aparicio-Ozores, Gerardo
    Castelan-Vega, Juan A.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 88 (88)
  • [37] Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main Protease
    Nar, Herbert
    Schnapp, Gisela
    Hucke, Oliver
    Hardman, Timothy C.
    Klein, Thomas
    CHEMMEDCHEM, 2021, 16 (09) : 1425 - 1426
  • [38] Structure-based identification of potential SARS-CoV-2 main protease inhibitors
    Khan, Shama
    Fakhar, Zeynab
    Hussain, Afzal
    Ahmad, Aijaz
    Jairajpuri, Deeba Shamim
    Alajmi, Mohamed F.
    Hassan, Md. Imtaiyaz
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (08) : 3595 - 3608
  • [39] The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
    Pang, Xiaojing
    Liu, Yang
    Li, Hua
    Chen, Lixia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
  • [40] Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors:in silicoanalysis
    Al-Sehemi, Abdullah G.
    Pannipara, Mehboobali
    Parulekar, Rishikesh S.
    Patil, Omkar
    Choudhari, Prafulla B.
    Bhatia, M. S.
    Zubaidha, P. K.
    Tamboli, Yasinalli
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (15) : 5804 - 5818
12345